-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Qz4zGYd9aQ5oMIKmk3V0cYIdYmQZCyc4JVLSU0Nhay1nyakSYhz3CrZaEThRvPYm SEpHyek1F0Khgf5ldLV5HQ== 0000950117-08-001521.txt : 20081210 0000950117-08-001521.hdr.sgml : 20081210 20081210154917 ACCESSION NUMBER: 0000950117-08-001521 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20081208 FILED AS OF DATE: 20081210 DATE AS OF CHANGE: 20081210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hamelin Paul CENTRAL INDEX KEY: 0001364190 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 081241072 BUSINESS ADDRESS: BUSINESS PHONE: 732-418-9300 MAIL ADDRESS: STREET 1: C/O SAVIENT PHARMACEUTICALS, INC. STREET 2: ONE TOWER CENTER BOULEVARD, 14TH FLOOR CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 4 1 rsr_15982.xml FORM 4 X0303 4 2008-12-08 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001364190 Hamelin Paul C/O SAVIENT PHARMACEUTICALS, INC ONE TOWER CENTER BLVD, 14TH FLOOR EAST BRUNSWICK NJ 08816 0 1 0 0 President Common Stock, $0.1 par value per share 2008-12-08 4 A 0 6333 4.53 A 51326 D Common Stock, $0.1 par value per share 2008-12-09 4 S 0 2450 4.71 D 48876 D Common Stock, $0.1 par value per share 2008-12-09 4 S 0 65 4.83 D 48811 D The right to receive these shares is pursuant to a restricted stock grant, a portion of which vested on December 8, 2008. These shares were sold automatically pursuant to a binding contract under 10b5-1 of the Securities Exchange Act to cover tax withholding obligations in connection with the vesting of restricted stock granted on December 8, 2006. By: /s/ Irina Azer as Attorney-In-Fact for 2008-12-10 -----END PRIVACY-ENHANCED MESSAGE-----